Skip to Content

'
Xiaojun Liu, Ph.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1901 East Road
Unit Number: Experimental Therapeutics -1950
Houston, TX 77054
Room Number: 4SCR3.1039
Phone: 713-563-6963
Email: xiaoliu@mdanderson.org

Education & Training

Degree-Granting Education

1998 China Pharmaceutical University, Nanjing, Jiangsu, China, PHD, Biopharmacy

Experience/Service

Academic Appointments

Instructor, Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 5/2008-8/2011

Other Appointments/Responsibilities

Research Scientist, The University of Texas MD Anderson Cancer Center, Houston, TX, 11/2006-4/2008

Selected Publications

Peer-Reviewed Original Research Articles
1. Wang Y, Liu X (co-1st author), Matsuda A, Plunkett W. Repair of 2'-C-Cyano-2'-Deoxy-1-beta-D-arabino-Pentofuranosylcytosine-Induced DNA Single-Strand Breaks by Transcription-coupled Nucleotide Excision Repair. Cancer Res 68(10):3881-9, 5/2008. PMID: 18483273.
2. Liu X, Guo Y, Li Y, Jiang Y, Chubb S, Azuma A, Huang P, Matsuda A, Hittelman W, Plunkett W. Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-β-D-arabino-pentofuranosylcytosine (CNDAC) and consequences of checkpoint abrogation. Cancer Res 65(15):6874-6881, 8/1/2005. PMID: 16061671.
3. He GA, Hou HM, Liu XJ. Naltrexone microspheres: in vitro release and effect on morphine analgesia in mice. Acta Pharmacol Sin 22(6):530-533, 6/2001. PMID: 11747760.
4. Yu L, Liu X, He G and Chai J. Cloning and expression of Mutant RP2-dSer6 gene. High Technology Letters (Ch) 10(3):5-8, 2000.
5. Liu XJ, Chai JH. Cloning, sequencing and preliminary expression of human RP2 gene. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 32(2):197-199, 2000. PMID: 12098802.
6. Liu X, Chai J. Progress in the pre-clinical study of retinitis pigmentosa treatment (Review). Progress in Biotechnology (Ch) 20(2):16-19, 2000.
7. Liu X, Wu W, Zhang L and Gao X. Study on the gene transcription level of hippocampus NGF in C57 mouse development. Journal of Chinese Pharmaceutical Sciences (Eng) 9(2):108-111, 2000.
8. Liu XJ, Wu WT. Effects of ligustrazine, tanshinone IIA, ubiquinone and idebenone on mouse water maze performance. Acta Pharmacologica Sinica 20(11):987-990, 11/1999. PMID: 11270979.
9. Zhang Y, Wu T, Wang M, Wu W, Zheng H, Zhang Z, Liu X. Chemical Synthesis, Cloning and Expression of the Gene for Novel Human Calcitonin Analogue. Pharmaceutical Biotechnology (Ch) 6(3):129-134, 1999.
10. Liu X, Wu W, Gao X. Purification and Bioassay of mouse βNGF Antibody. Journal of Chinese Pharmaceutical Sciences (Eng) 7(1):43-47, 1998.
11. Liu X, Wu W. Progress in the Research of Neurotrophic Factors (Review). Chinese Journal of Biochemical Pharmaceutics (Ch) 18(4):213-216, 1997.
12. Liu X, Wu W, Gao X. Purification and Bioassay of Mouse βNGF and Its Antibody. Pharmaceutical Biotechnology (Ch) 4(1):22-27, 1997.
13. Liu X, Wu W, Gao X. NGF and the Treatment of Alzheimer's Disease (Review). Progress in Pharmaceutical Sciences (Ch) 19(1):5-9, 1995.
14. Liu X, Wu W. Preparation of Cerebrosides and Study on Their Anti-ulcerogenic Activity. Pharmaceutical Biotechnology (Ch) 2(3):19-23, 1995.

Last updated: 2/26/2013